Regular physical activity not only aids in weight management but also improves gastrointestinal motility, potentially reducing the risk of heartburn
death from either MTC or pheochromocytoma most commonly occurred in the mid 50s, although earlier death does occur
Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-beta activation
Medical Weight Loss at a Glance EXPECTED RESULTS Sustainable fat loss, increased energy, appetite control, improved metabolic function, and reduced inflammation TREATMENT LENGTH Initial consult + ongoing weekly or biweekly check-ins
The hallmark symptom of acute pancreatitis is severe, persistent abdominal pain , typically described as: Located in the upper abdomen (epigastric or left upper quadrant) Radiating to the back in approximately 50% of cases, often described as a "band-like" distribution Sudden in onset and constant in nature, rather than colicky Worsening after eating , particularly after fatty meals Not relieved by simple analgesia or changes in position Accompanying symptoms frequently include: Nausea and vomiting that may be persistent and severe Fever and tachycardia as systemic inflammatory responses develop Abdominal distension and tenderness on examination Jaundice (in cases associated with gallstones or biliary obstruction) Signs of systemic compromise such as hypotension, confusion, or reduced urine output in severe cases Patients should be specifically counselled that these symptoms differ from the common gastrointestinal side effects of tirzepatide, such as mild nausea, occasional vomiting, or transient abdominal discomfort, which typically occur early in treatment and resolve spontaneously
